🟢 CDIO is trading 8.7% up today on Atlas Healthcare partnership momentum

CDIO is trading at $2.19 (8.7% up) in after-hours trading, extending a rebound following renewed attention on its partnership with Atlas Healthcare Physicians.

• The collaboration expands clinical access to the company's Epi+Gen CHD and PrecisionCHD cardiovascular tests.
• The move reflects sustained investor interest in the growth of the company's proprietary AI- and epigenetics-based diagnostics platform.